1. Chilamakuri R, Agarwal S. COVID-19: Characteristics and Therapeutics. Cells. 2021 Jan 21; 10(2): 206. doi: 10.3390/cells10020206. PMID: 33494237; PMCID: PMC7909801.
2. Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz Martin AJ. Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. 2021 Mar; 46(3): 100742. doi: 10.1016/j.cpcardiol.2020.100742. Epub 2020 Nov 2. PMID: 33243440; PMCID: PMC7605852.
3. Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022 Mar 11; 375 (6585): 1122-1127. doi: 10.1126/science.abm8108. Epub 2022 Mar 10. PMID: 35271343.
4. Li N, Liu T, Chen H, Liao J, Li H, Luo Q, Song H, Xiang F, Tan J, Zhou J, Hu G, Yuan Z, Peng Y, Luo G. Management strategies for the burn ward during COVID-19 pandemic. Burns. 2020 Jun; 46(4):
756-761. doi: 10.1016/j.burns.2020.03.013. Epub 2020 Apr 2. PMID: 32381449; PMCID: PMC7127442.
5. Ladhani HA, Yowler CJ, Claridge JA. Burn Wound Colonization, Infection, and Sepsis. Surg Infect (Larchmt). 2021 Feb; 22(1): 44-48. doi: 10.1089/sur.2020.346. Epub 2020 Oct 20. PMID: 33085576.
6. Liu A, Minasian RA, Maniago E, Justin Gillenwater T, Garner WL, Yenikomshian HA. Venous Thromboembolism Chemoprophylaxis in Burn Patients: A Literature Review and Single-Institution Experience. J Burn Care Res. 2021 Feb 3; 42(1):
18-22. doi: 10.1093/jbcr/iraa143. PMID: 32842151.
7. Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest. 2021 Oct; 160(4): 1471-1480. doi: 10.1016/j.chest.2021.06.016. Epub 2021 Jun 19. PMID: 34153340; PMCID: PMC8213519.
8. Gallaher J, Abid M, Kayange L, Purcell L, Charles A. The effect of COVID-19 on burn management and outcomes in a resource-limited setting. Burns. 2022 Nov; 48(7): 1584-1589. doi: 10.1016/j.burns.2022.08.004. Epub 2022 Aug 13. PMID: 36038452; PMCID: PMC9375248.
9. Fayazov AD, Shukurov SI, Shukurov BI, Sultanov BC, Namazov AN, Ruzimuratov DA. Disorders of the immune system in severely burned patients. Ann Burns Fire Disasters. 2009 Sep 30; 22(3): 121-30. PMID: 21991166; PMCID: PMC3188142.
10. Davitt E, Davitt C, Mazer MB, Areti SS, Hotchkiss RS, Remy KE. COVID-19 disease and immune dysregulation. Best Pract Res Clin Haematol. 2022 Sep; 35(3): 101401. doi: 10.1016/j.beha.2022.101401. Epub 2022 Oct 15. PMID: 36494149; PMCID: PMC9568269.
11. Foncerrada G, Culnan DM, Capek KD,
González-Trejo S, Cambiaso-Daniel J, Woodson LC, Herndon DN, Finnerty CC, Lee JO. Inhalation Injury in the Burned Patient. Ann Plast Surg. 2018
Mar; 80 (3 Suppl 2): S98-S105. doi: 10.1097/SAP.0000000000001377. PMID: 29461292; PMCID: PMC5825291.
12. Keshavarzi A, Mohammadi AA, Ayaz M, Javanmardi F, Hoghoughi MA, Shirazi Yeganeh B, Emami A, Mackie M, Akrami R, Iranpak S. Cutaneous Vesicular of COVID-19 in Two Burn Patients. World J Plast Surg. 2020 Sep; 9(3):
331-338. doi: 10.29252/wjps.9.3.331. PMID: 33330012; PMCID: PMC7734937.
13. Otaghvar HA, Rouzbahani AK, Mahmoudvand G, Moghaddam S, Afkham SA, Razavi ZS. A Brief Report on the Effect of Covid 19 Pandemic on Patients Undergoing Skin Graft Surgery in a Burns Hospital from March 2019 to March 2020. J Case Rep Med Hist. 2022; 2(8).
14. Elfiah U, Perdanakusuma DS, Dososaputra I, Riasa IN, Lumintang LM, Naufal MF. Skin graft as a modality reconstruction of post-burn contractures during pandemic area: case series. Bali Medical Journal. 2023 Jan 11; 12(1): 244-8.
